STUDIES ON THE ABSORPTION AND EXCRETION OF TRIPOTASSIUM DICITRATO-BISMUTHATE IN MAN

1 January 1981

journal article
research article

Vol. 34 (2) , 359-364

Abstract

In 8 volunteers blood and urine bismuth levels were detected after a 5-day course of tripotassium dicitratobismuthate [a drug apparently effective in promoting ulcer healing of gastric and duodenal ulcers] and rose further with increasing dose. In 24 patients, blood and urine bismuth were measured on the last day of treatment. There was no significant difference (P > 0.2) in blood or urine bismuth levels among patients treated for 4, 5 or 6 wk with colloidal bismuth. None of the blood level measurements exceeced 50 .mu.g/l. Bismuth was slowly eliminated in the urine after stopping treatment.

This publication has 2 references indexed in Scilit:

BISMUTH TOXICITY IN MAN .1. BISMUTH BLOOD AND URINE LEVELS IN PATIENTS AFTER ADMINISTRATION OF A BISMUTH PROTEIN COMPLEX (BICITROPEPTIDE)
1979
DOUBLE-BLIND CONTROLLED TRIAL WITH COLLOIDAL BISMUTH SUBCITRATE IN THE TREATMENT OF SYMPTOMATIC DUODENAL ULCERS, WITH SPECIAL REFERENCES TO BLOOD AND URINE BISMUTH LEVELS
1979